A New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology? - 27/07/12

Doi : 10.1016/j.hlc.2012.04.010

Gerald F. Watts ^a,^⁎ , David R. Sullivan ^b, Frank M. van Bockxmeer ^c, Nicola Poplawski ^d, Ian Hamilton-Craig ^e, Peter M. Clifton ^f, Richard C. O’Brien ^g, Warrick Bishop ^h, Peter M. George ⁱ, Christopher Semsarian ^j, Andrew Tonkin ^k
for the Familial Hypercholesterolaemia Australasia Network
^a Lipid Disorders Clinic, Metabolic Research Centre, Department of Internal Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia
^b Department of Biochemistry and Lipid Clinic, Royal Prince Alfred Hospital, University of Sydney, New South Wales, Australia
^c Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA, Royal Perth Hospital, University of Western Australia, Australia
^d South Australia Clinical Genetics Service, Genetics and Molecular Pathology Directorate, Women’s & Children’s Hospital, Adelaide, South Australia, Australia
^e Preventive Cardiology and Lipid Clinic, Gold Coast Hospital, Griffith University, Queensland, Australia
^f Baker IDI Heart and Diabetes Institute, Adelaide, South Australia, Australia
^g Department of Medicine, Diabetes and Endocrinology, Austin Hospital, University of Melbourne, Melbourne, Victoria, Australia
^h Department of Cardiology, Calvary Cardiac Centre, Calvary Health Care, Tasmania, Australia
ⁱ Biochemistry and Pathology, Canterbury Health Laboratories, Lipid Clinic, Christchurch Hospital, University of Otago, Christchurch, New Zealand
^j Department of Cardiology, Royal Prince Alfred Hospital and Sydney Medical School, University of Sydney, New South Wales, Australia
^k Cardiovascular Research Unit, Monash University, Melbourne, Victoria, Australia

Corresponding author at: GPO Box X2213, Perth, WA 6847, Australia. Tel.: +61 8 9224 0245.

Résumé

Familial hypercholesterolaemia (FH) is a co-dominantly inherited disorder that causes marked elevation in plasma cholesterol and premature coronary heart disease. There are at least 45,000 people with FH in Australia and New Zealand, but most remain undiagnosed and undertreated. To bridge this gap in coronary prevention the FH Australasia Network has developed a model of care for FH. We present the executive summary, with a commentary contrasting the recommendations with other international guidelines and highlighting the role of the cardiologist.

Le texte complet de cet article est disponible en PDF.

Keywords : Familial hypercholesterolaemia, Model of care, Role of cardiology

Plan

Context

Australasian Model of Care for Familial Hypercholesterolaemia

Export

Vol 21 - N° 9

P. 543-550 - septembre 2012 Retour au numéro

Article précédent

Cell Therapy for Left Ventricular Dysfunction: An Overview for Cardiac Clinicians
James J.H. Chong

| Article suivant

Recombinant B-type Natriuretic Peptide Nesiritide Attenuates Vascular Remodelling by Reducing Plasma Aldosterone in Rabbits
Shu-Qin Liu, Hong-Wen Xie, Huang-Ying Yan, Yu-Qiao Lu, Le-Xin Wang

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

A New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology? - 27/07/12

Résumé

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL